Back

Patchouli alcohol suppresses gastric cancer growth and immune evasion via inhibition of the NF-κB/PD-L1 axis

Hou, K.; Hao, Q.; Yang, H.; Dai, F.; Wang, X.; Dai, Y. w.; Feng, L.; Lu, H.; Wang, Z.

2026-03-19 pharmacology and toxicology
10.64898/2026.03.17.712304 bioRxiv
Show abstract

ObjectiveThis study aimed to investigate the anti-gastric cancer effect of Patchouli alcohol (PA), especially its influence on PD-L1-mediated immune evasion, and to elucidate the underlying molecular mechanisms. MethodsA CCK-8 assay was used to evaluate the effects of PA on the viability of the gastric cancer cell lines HGC-27 and MKN-45. RT-qPCR and western blotting were performed to analyze the mRNA and protein levels of NF-{kappa}B and PD-L1, respectively. In a coculture system of gastric cancer cells and peripheral blood mononuclear cells (PBMCs), the effect of PA pretreatment on the PBMC-induced apoptosis of cancer cells was analyzed by flow cytometry, and the cytotoxic activity of the PBMCs was assessed by a lactate dehydrogenase (LDH) release assay. Flow cytometry was also used to determine the proportions of CD3CD8 T cells and IFN-{gamma}CD8 T cells. ELISA was used to measure the levels of IFN-{gamma}, TNF-, and granzyme B in the coculture supernatants. Immunofluorescence staining was conducted to assess NF-{kappa}B nuclear translocation. In a mouse xenograft model, tumor volume and weight were measured after 14 days of PA treatment. Histopathological changes and apoptosis were analyzed by HE and TUNEL staining. A luciferase reporter assay was used to examine the transcriptional regulation of PD-L1 by NF-{kappa}B. ResultsPA inhibited the viability of HGC-27 and MKN-45 cells in a dose- and time-dependent manner and significantly downregulated the expression of NF-{kappa}B and PD-L1 at both the mRNA and protein levels. In a PBMC coculture model, PA pretreatment enhanced the ability of PBMCs to induce apoptosis and directly kill gastric cancer cells. Furthermore, PA pretreatment increased the proportions of CD3CD8 T cells and IFN-{gamma}CD8 T cells in a dose-dependent manner. Consistent with this immunostimulatory effect, PA increased the levels of IFN-{gamma}, TNF-, and granzyme B in the coculture supernatants. Mechanistically, western blotting analysis demonstrated that PA significantly reduced the protein levels of AKT, NF-{kappa}B, and PD-L1 in gastric cancer cells. Immunofluorescence staining further indicated that PA suppressed the nuclear translocation of NF-{kappa}B. In a mouse xenograft model, PA treatment significantly inhibited tumor growth, induced apoptosis, and downregulated NF-{kappa}B and PD-L1 protein expression in tumor tissues. Flow cytometry of tumor-infiltrating lymphocytes revealed increased proportions of CD3CD8 and IFN-{gamma}CD8 T cells following PA treatment. Finally, luciferase reporter assays demonstrated that NF-{kappa}B directly regulates PD-L1 transcription by binding to its promoter region. ConclusionPA exerts antitumor effects in gastric cancer by suppressing the NF-{kappa}B/PD-L1 axis, thereby enhancing CD8 T-cell-mediated cytotoxicity and inhibiting immune evasion.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 9%
18.9%
2
Cancer Medicine
24 papers in training set
Top 0.1%
10.3%
3
Frontiers in Nutrition
23 papers in training set
Top 0.1%
9.3%
4
Frontiers in Pharmacology
100 papers in training set
Top 0.3%
6.9%
5
BioMed Research International
25 papers in training set
Top 0.5%
4.4%
6
BMC Cancer
52 papers in training set
Top 0.4%
4.4%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 40%
3.3%
8
PeerJ
261 papers in training set
Top 5%
2.1%
9
Pharmaceuticals
33 papers in training set
Top 0.4%
2.1%
10
Journal of Agricultural and Food Chemistry
14 papers in training set
Top 0.5%
1.8%
11
Life Sciences
25 papers in training set
Top 0.5%
1.7%
12
International Journal of Molecular Sciences
453 papers in training set
Top 9%
1.5%
13
Clinical and Translational Medicine
30 papers in training set
Top 0.4%
1.5%
14
Journal of Translational Medicine
46 papers in training set
Top 1%
1.4%
15
Toxicological Sciences
38 papers in training set
Top 0.4%
1.4%
16
Cell Death Discovery
51 papers in training set
Top 0.8%
1.2%
17
PNAS Nexus
147 papers in training set
Top 1.0%
0.9%
18
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.8%
0.9%
19
Annals of Oncology
13 papers in training set
Top 0.8%
0.9%
20
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.7%
0.9%
21
Nature Communications
4913 papers in training set
Top 59%
0.9%
22
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.5%
0.9%
23
Gene
41 papers in training set
Top 2%
0.8%
24
Cancers
200 papers in training set
Top 5%
0.8%
25
Molecules
37 papers in training set
Top 2%
0.8%
26
Cancer Letters
32 papers in training set
Top 0.8%
0.7%
27
Journal of Clinical Medicine
91 papers in training set
Top 7%
0.7%
28
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.5%
0.7%
29
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 1%
0.7%
30
Acta Biochimica et Biophysica Sinica
19 papers in training set
Top 1%
0.7%